Consolidated Statements of Cash Flows (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Operating Activities
Net loss	$ (15,171,000)	$ (11,039,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization of property and equipment	2,912,000	1,661,000
Amortization of intangible assets	2,812,000	1,807,000
Amortization of debt discounts and deferred financing costs	1,689,000	921,000
Impairment charge	920,000
Provision of doubtful accounts	283,000	4,000
Deferred tax benefit	(146,000)	(6,586,000)
Share-based compensation expense	2,045,000	2,343,000
Accretion of contingent consideration	265,000	450,000
Change in fair value of contingent consideration	(250,000)
Loss on sale of property and equipment	136,000	49,000
Changes in (net of acquisitions):
Accounts receivable	23,812,000	13,898,000
Unbilled revenue	3,781,000	2,594,000
Costs in excess of billings on uncompleted projects	(9,274,000)	(66,148,000)
Inventories	(4,744,000)	2,616,000
Prepaid expenses and other assets	1,417,000	451,000
Accounts payable and other liabilities	(19,084,000)	(5,741,000)
Income taxes payable / receivable	14,376,000	(131,000)
Billings in excess of costs on uncompleted projects	10,397,000	2,027,000
Deferred revenue	7,318,000
Net cash provided by (used in) operating activities	23,494,000	(60,824,000)
Investing Activities
Purchases of property and equipment	(6,486,000)	(1,296,000)
Proceeds from the sale of property and equipment	21,000
Purchase of assets of the Custom Solutions Group of Cellular Specialties, Inc.		(18,000,000)
Change in restricted cash		(7,727,000)
Change in due from shareholders	1,000	(9,000)
Net cash used in investing activities	(6,464,000)	(27,032,000)
Financing Activities
Proceeds from lines of credit	491,320,000
Payments on lines of credit	(491,320,000)
Payments on capital lease and notes payable obligations	(4,379,000)	(268,000)
Payments on contingent consideration arrangements	(141,000)
Payments for deferred financing costs	(1,255,000)	(4,026,000)
Proceeds from the issuance of common stock		13,000
Proceeds from exercise of warrants and stock options	43,000
Purchase of treasury stock		(4,995,000)
Net cash used in financing activities	(5,732,000)	(9,276,000)
Increase (decrease) in cash	11,298,000	(97,132,000)
Cash, Beginning of Period	59,439,000	120,991,000
Cash, End of Period	70,737,000	23,859,000
Supplemental Cash Flow Information
Cash paid for interest	21,580,000	14,755,000
Cash paid for income taxes	897,000	53,000
Supplemental Non-Cash Investing and Finance Activities
Purchase of property and equipment financed through capital leases and other financing arrangements	404,000	69,000
Noncash exchange of liability awards for equity awards		$ 712,000